- 著者
-
Morito Keiko
Hirose Toshiharu
Kinjo Junei
HIRAKAWA Tomoki
OKAWA Masafumi
NOHARA Toshihiro
OGAWA Sumito
INOUE Satoshi
MURAMATSU Masami
MASAMUNE Yukito
- 出版者
- 公益社団法人日本薬学会
- 雑誌
- Biological & pharmaceutical bulletin (ISSN:09186158)
- 巻号頁・発行日
- vol.24, no.4, pp.351-356, 2001-04-01
- 被引用文献数
-
26
471
The human estrogen receptor(hER) exists as two subtypes, hER α and hER β, that differ in the C-terminal ligand-binding domain and in the N-terminal transactivation domain. In this study, we investigated the estrogenic activities of soy isoflavones after digestion with enteric bacteria in competition binding assays with hER α or hER β protein, and in a gene expression assay using a yeast system. The estrogenic activities of these isoflavones were also investigated by the growth of MCF-7 breast cancer cells. Isoflavone glycoside binds weakly to both receptors and estrogen receptor-dependent transcriptional expression is poor. The aglycones bind more strongly to hER hER β than to hER α. The binding affinities of genistein, dihydrogenistein and equol are comparable to the binding affinity of 17 β-estradiol. Equol induces transcription most strongly with hER α and β. The concentration required for maximal gene expression is much higher than expected from the binding affinities of the compounds, and the maximal activity induced by these compounds is about half activity of 17 β-estradiol. Although genistin binds more weakly to the receptors and induces transcription less than does genistein, it stimulates the growth of MCF-7 cells more strongly than does genistein.